$Progenity, Inc.(PROG)$ Correct me if I’m wrong but that patent for treating diseases of the gastrointestinal tract with a SMAD7 inhibitor is a 15 billion dollar market not to mention global Biological market is 250 billion. I wonder if any other company treats the GI TRACT. If Progenity can deliver on this and make billions off this product like no joke I’ll see a 30 plus share price.
精彩评论